IBDEI038 ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2866,1,4,0)
 ;;=4^M76.01
 ;;^UTILITY(U,$J,358.3,2866,2)
 ;;=^5013267
 ;;^UTILITY(U,$J,358.3,2867,0)
 ;;=M76.22^^18^201^6
 ;;^UTILITY(U,$J,358.3,2867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2867,1,3,0)
 ;;=3^Iliac crest spur, left hip
 ;;^UTILITY(U,$J,358.3,2867,1,4,0)
 ;;=4^M76.22
 ;;^UTILITY(U,$J,358.3,2867,2)
 ;;=^5013274
 ;;^UTILITY(U,$J,358.3,2868,0)
 ;;=M76.21^^18^201^7
 ;;^UTILITY(U,$J,358.3,2868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2868,1,3,0)
 ;;=3^Iliac crest spur, right hip
 ;;^UTILITY(U,$J,358.3,2868,1,4,0)
 ;;=4^M76.21
 ;;^UTILITY(U,$J,358.3,2868,2)
 ;;=^5013273
 ;;^UTILITY(U,$J,358.3,2869,0)
 ;;=M54.18^^18^201^8
 ;;^UTILITY(U,$J,358.3,2869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2869,1,3,0)
 ;;=3^Radiculopathy, sacral and sacrococcygeal region
 ;;^UTILITY(U,$J,358.3,2869,1,4,0)
 ;;=4^M54.18
 ;;^UTILITY(U,$J,358.3,2869,2)
 ;;=^5012303
 ;;^UTILITY(U,$J,358.3,2870,0)
 ;;=M54.32^^18^201^9
 ;;^UTILITY(U,$J,358.3,2870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2870,1,3,0)
 ;;=3^Sciatica, left side
 ;;^UTILITY(U,$J,358.3,2870,1,4,0)
 ;;=4^M54.32
 ;;^UTILITY(U,$J,358.3,2870,2)
 ;;=^5012307
 ;;^UTILITY(U,$J,358.3,2871,0)
 ;;=M54.31^^18^201^10
 ;;^UTILITY(U,$J,358.3,2871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2871,1,3,0)
 ;;=3^Sciatica, right side
 ;;^UTILITY(U,$J,358.3,2871,1,4,0)
 ;;=4^M54.31
 ;;^UTILITY(U,$J,358.3,2871,2)
 ;;=^5012306
 ;;^UTILITY(U,$J,358.3,2872,0)
 ;;=M99.04^^18^201^12
 ;;^UTILITY(U,$J,358.3,2872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2872,1,3,0)
 ;;=3^Segmental and somatic dysfunction of sacral region
 ;;^UTILITY(U,$J,358.3,2872,1,4,0)
 ;;=4^M99.04
 ;;^UTILITY(U,$J,358.3,2872,2)
 ;;=^5015404
 ;;^UTILITY(U,$J,358.3,2873,0)
 ;;=M99.05^^18^201^11
 ;;^UTILITY(U,$J,358.3,2873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2873,1,3,0)
 ;;=3^Segmental and somatic dysfunction of pelvic region
 ;;^UTILITY(U,$J,358.3,2873,1,4,0)
 ;;=4^M99.05
 ;;^UTILITY(U,$J,358.3,2873,2)
 ;;=^5015405
 ;;^UTILITY(U,$J,358.3,2874,0)
 ;;=S33.6XXA^^18^201^13
 ;;^UTILITY(U,$J,358.3,2874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2874,1,3,0)
 ;;=3^Sprain of sacroiliac joint, initial encounter
 ;;^UTILITY(U,$J,358.3,2874,1,4,0)
 ;;=4^S33.6XXA
 ;;^UTILITY(U,$J,358.3,2874,2)
 ;;=^5025175
 ;;^UTILITY(U,$J,358.3,2875,0)
 ;;=S33.6XXS^^18^201^14
 ;;^UTILITY(U,$J,358.3,2875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2875,1,3,0)
 ;;=3^Sprain of sacroiliac joint, sequela
 ;;^UTILITY(U,$J,358.3,2875,1,4,0)
 ;;=4^S33.6XXS
 ;;^UTILITY(U,$J,358.3,2875,2)
 ;;=^5025177
 ;;^UTILITY(U,$J,358.3,2876,0)
 ;;=S33.6XXD^^18^201^15
 ;;^UTILITY(U,$J,358.3,2876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2876,1,3,0)
 ;;=3^Sprain of sacroiliac joint, subsequent encounter
 ;;^UTILITY(U,$J,358.3,2876,1,4,0)
 ;;=4^S33.6XXD
 ;;^UTILITY(U,$J,358.3,2876,2)
 ;;=^5025176
 ;;^UTILITY(U,$J,358.3,2877,0)
 ;;=M12.9^^18^202^1
 ;;^UTILITY(U,$J,358.3,2877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2877,1,3,0)
 ;;=3^Arthropathy, unspecified
 ;;^UTILITY(U,$J,358.3,2877,1,4,0)
 ;;=4^M12.9
 ;;^UTILITY(U,$J,358.3,2877,2)
 ;;=^5010666
 ;;^UTILITY(U,$J,358.3,2878,0)
 ;;=M71.50^^18^202^2
 ;;^UTILITY(U,$J,358.3,2878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2878,1,3,0)
 ;;=3^Bursitis, unspec site NEC
 ;;^UTILITY(U,$J,358.3,2878,1,4,0)
 ;;=4^M71.50
 ;;^UTILITY(U,$J,358.3,2878,2)
 ;;=^5013190
 ;;^UTILITY(U,$J,358.3,2879,0)
 ;;=M62.9^^18^202^3
 ;;^UTILITY(U,$J,358.3,2879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2879,1,3,0)
 ;;=3^Disorder of muscle, unspecified
 ;;^UTILITY(U,$J,358.3,2879,1,4,0)
 ;;=4^M62.9
 ;;^UTILITY(U,$J,358.3,2879,2)
 ;;=^5012684
 ;;^UTILITY(U,$J,358.3,2880,0)
 ;;=M71.10^^18^202^5
 ;;^UTILITY(U,$J,358.3,2880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2880,1,3,0)
 ;;=3^Infective bursitis, unspecified site
 ;;^UTILITY(U,$J,358.3,2880,1,4,0)
 ;;=4^M71.10
 ;;^UTILITY(U,$J,358.3,2880,2)
 ;;=^5013123
 ;;^UTILITY(U,$J,358.3,2881,0)
 ;;=M62.838^^18^202^6
 ;;^UTILITY(U,$J,358.3,2881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2881,1,3,0)
 ;;=3^Muscle spasm, other
 ;;^UTILITY(U,$J,358.3,2881,1,4,0)
 ;;=4^M62.838
 ;;^UTILITY(U,$J,358.3,2881,2)
 ;;=^5012682
 ;;^UTILITY(U,$J,358.3,2882,0)
 ;;=M79.2^^18^202^8
 ;;^UTILITY(U,$J,358.3,2882,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2882,1,3,0)
 ;;=3^Neuralgia and neuritis, unspecified
 ;;^UTILITY(U,$J,358.3,2882,1,4,0)
 ;;=4^M79.2
 ;;^UTILITY(U,$J,358.3,2882,2)
 ;;=^5013322
 ;;^UTILITY(U,$J,358.3,2883,0)
 ;;=M25.50^^18^202^9
 ;;^UTILITY(U,$J,358.3,2883,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2883,1,3,0)
 ;;=3^Pain in unspecified joint
 ;;^UTILITY(U,$J,358.3,2883,1,4,0)
 ;;=4^M25.50
 ;;^UTILITY(U,$J,358.3,2883,2)
 ;;=^5011601
 ;;^UTILITY(U,$J,358.3,2884,0)
 ;;=M96.1^^18^202^10
 ;;^UTILITY(U,$J,358.3,2884,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2884,1,3,0)
 ;;=3^Postlaminectomy syndrome NEC
 ;;^UTILITY(U,$J,358.3,2884,1,4,0)
 ;;=4^M96.1
 ;;^UTILITY(U,$J,358.3,2884,2)
 ;;=^5015374
 ;;^UTILITY(U,$J,358.3,2885,0)
 ;;=M54.10^^18^202^11
 ;;^UTILITY(U,$J,358.3,2885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2885,1,3,0)
 ;;=3^Radiculopathy, site unspecified
 ;;^UTILITY(U,$J,358.3,2885,1,4,0)
 ;;=4^M54.10
 ;;^UTILITY(U,$J,358.3,2885,2)
 ;;=^5012295
 ;;^UTILITY(U,$J,358.3,2886,0)
 ;;=M47.10^^18^202^13
 ;;^UTILITY(U,$J,358.3,2886,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2886,1,3,0)
 ;;=3^Spondylosis w/ myelopathy, other, site unspec
 ;;^UTILITY(U,$J,358.3,2886,1,4,0)
 ;;=4^M47.10
 ;;^UTILITY(U,$J,358.3,2886,2)
 ;;=^5012050
 ;;^UTILITY(U,$J,358.3,2887,0)
 ;;=M43.10^^18^202^12
 ;;^UTILITY(U,$J,358.3,2887,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2887,1,3,0)
 ;;=3^Spondylolisthesis, site unspecified
 ;;^UTILITY(U,$J,358.3,2887,1,4,0)
 ;;=4^M43.10
 ;;^UTILITY(U,$J,358.3,2887,2)
 ;;=^5011921
 ;;^UTILITY(U,$J,358.3,2888,0)
 ;;=M79.1^^18^202^7
 ;;^UTILITY(U,$J,358.3,2888,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2888,1,3,0)
 ;;=3^Myalgia
 ;;^UTILITY(U,$J,358.3,2888,1,4,0)
 ;;=4^M79.1
 ;;^UTILITY(U,$J,358.3,2888,2)
 ;;=^5013321
 ;;^UTILITY(U,$J,358.3,2889,0)
 ;;=M79.7^^18^202^4
 ;;^UTILITY(U,$J,358.3,2889,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2889,1,3,0)
 ;;=3^Fibromyalgia
 ;;^UTILITY(U,$J,358.3,2889,1,4,0)
 ;;=4^M79.7
 ;;^UTILITY(U,$J,358.3,2889,2)
 ;;=^46261
 ;;^UTILITY(U,$J,358.3,2890,0)
 ;;=99605^^19^203^1^^^^1
 ;;^UTILITY(U,$J,358.3,2890,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2890,1,2,0)
 ;;=2^MTMS BY PHARM,INIT 15 MIN
 ;;^UTILITY(U,$J,358.3,2890,1,3,0)
 ;;=3^99605
 ;;^UTILITY(U,$J,358.3,2891,0)
 ;;=99607^^19^203^2^^^^1
 ;;^UTILITY(U,$J,358.3,2891,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2891,1,2,0)
 ;;=2^MTMS BY PHARM, EA ADDL 15 MIN
 ;;^UTILITY(U,$J,358.3,2891,1,3,0)
 ;;=3^99607
 ;;^UTILITY(U,$J,358.3,2892,0)
 ;;=99606^^19^204^1^^^^1
 ;;^UTILITY(U,$J,358.3,2892,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2892,1,2,0)
 ;;=2^MTMS BY PHARM,INIT 15 MIN
 ;;^UTILITY(U,$J,358.3,2892,1,3,0)
 ;;=3^99606
 ;;^UTILITY(U,$J,358.3,2893,0)
 ;;=99607^^19^204^2^^^^1
 ;;^UTILITY(U,$J,358.3,2893,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2893,1,2,0)
 ;;=2^MTMS BY PHARM, EA ADDL 15 MIN
 ;;^UTILITY(U,$J,358.3,2893,1,3,0)
 ;;=3^99607
 ;;^UTILITY(U,$J,358.3,2894,0)
 ;;=98960^^19^205^1^^^^1
 ;;^UTILITY(U,$J,358.3,2894,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2894,1,2,0)
 ;;=2^INDIVIDUAL PATIENT, EA 30 MIN
 ;;^UTILITY(U,$J,358.3,2894,1,3,0)
 ;;=3^98960
 ;;^UTILITY(U,$J,358.3,2895,0)
 ;;=98961^^19^205^2^^^^1
 ;;^UTILITY(U,$J,358.3,2895,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2895,1,2,0)
 ;;=2^2-4 PATIENTS, EA 30 MIN
 ;;^UTILITY(U,$J,358.3,2895,1,3,0)
 ;;=3^98961
 ;;^UTILITY(U,$J,358.3,2896,0)
 ;;=98962^^19^205^3^^^^1
 ;;^UTILITY(U,$J,358.3,2896,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2896,1,2,0)
 ;;=2^5-8 PATIENTS, EA 30 MIN
